Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: A.4 Lucinactant
Total 0 results
Nothing found
Sponsors and Collaborators
The Australia-Israel Scientific Exchange Foundation (AISEF)
Sahachat Aueyingsak
Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
Hospitales Universitarios Virgen del Rocío
Glasgow Western Infirmary
National Institute of Cardiovascular Diseases, Bangladesh
Daniela Pacella - University of Naples Federico II, Naples
ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
Bassam Abdulkarim
Etan Orgel
IRCCS Istituto Auxologico Italiano, Milano, Italy
Åke Wibergs Stiftelse
Centro Universitário Franciscano
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Sublimity Therapeutics Holdco Limited
Dr Philippe METELLUS
AlpinARC
Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
the people hospital of Linzhi
ECMC
View Full List
Medical Conditions
Degenerative Spondylolisthesis G1
Patients With Leptomeningeal Disease
Value-Based Health Insurance
Legal History
Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
Transitional Cell Carcinoma of Renal Pelvis
Adult Patients Undergoing Surgery That Requires General Anesthesia
Orthopaedic Disorders
Panniculectomy
Genetic Risk Factor
Ability to Swim 100m Independent Freestyle
Initiation of Depo-Provera (DMPA)
Interviews
Hyperprolinemia
Very Long Chain Acyl Coa Dehydrogenase Deficiency
Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
Bladder Cancer TNM Staging Primary Tumor (T) T2B
Progression to PD-1 Antibody
Pancreaticoduodenectomy
Eosinophil Blood Count
View Full List
Drug Interventions
Epirubicin hydrochloride
ASP8062
Omeprazole 20mg
IV rtPA (intravenous recombinant plasminogen activator)
Cefuroxime 750mg oral
0% N2O
Mepivacaine
Gefitinib
Erythropoietin
Metoclopramide + dexamethasone
Antibiotic treatment
UFUR and Iressa
Prasugrel
Injectable Insulin
ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
Nimotuzumab
6% hetastarch
Paliperidone palmitate
5-Fluoro-uracil
HBM4003 and Triprilimab
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Chile
Contract Research Organizations in Germany
Contract Research Organizations in India
Contract Research Organizations in Japan
Contract Research Organizations in Mauritius
Contract Research Organizations in Norway
Contract Research Organizations in Philippines
Contract Research Organizations in Russia
Contract Research Organizations in Slovenia
Contract Research Organizations in South Africa
Contract Research Organizations in Taiwan
CRO list by country
CROs in Hong Kong
Syneos Health
Medpace
ICON
Chinese University of Hong Kong
Fortrea
Gene Company
Hong Kong Institute of Biotechnology
Groken Bioscience
Advanced Technology & Industrial Co
Celero
All CROs in Hong Kong
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe